Taken together, the experimental studies have shown that FBLN5 is neuroprotective for ischemic stroke, whereas clinical studies have found that higher plasma FBLN5 levels in an acute phase are associated with more severe ischemic or hemorrhagic strokes with worse outcomes. Here, FBLN5 is linked to hemorrhagic stroke.